WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H406376
CAS#: 1016971-82-6
Description: INH-13 is a Aurora inhibitor.
Hodoodo Cat#: H406376
Name: INH-13
CAS#: 1016971-82-6
Chemical Formula: C28H31N7O4
Exact Mass: 529.24
Molecular Weight: 529.590
Elemental Analysis: C, 63.50; H, 5.90; N, 18.51; O, 12.08
Synonym: INH13; INH 13; INH-13.
IUPAC/Chemical Name: N-(5-((7-(2-hydroxy-3-(piperidin-1-yl)propoxy)-6-methoxyquinazolin-4-yl)amino)pyrimidin-2-yl)benzamide
InChi Key: WHHFZOIADLFZRX-UHFFFAOYSA-N
InChi Code: InChI=1S/C28H31N7O4/c1-38-24-12-22-23(13-25(24)39-17-21(36)16-35-10-6-3-7-11-35)31-18-32-26(22)33-20-14-29-28(30-15-20)34-27(37)19-8-4-2-5-9-19/h2,4-5,8-9,12-15,18,21,36H,3,6-7,10-11,16-17H2,1H3,(H,31,32,33)(H,29,30,34,37)
SMILES Code: O=C(NC1=NC=C(NC2=C3C=C(OC)C(OCC(O)CN4CCCCC4)=CC3=NC=N2)C=N1)C5=CC=CC=C5
Appearance: white solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 529.59 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1. Jayashankar, L.; Syama Sundar, B.. Quantitative structure activity relationship for the computational prediction of Aurora-B inhibitors. From Journal of Pharmaceutical Sciences and Research (2010), 2(4), 272-277.